Tens of millions of Americans are living with liver disease, which can be caused by heavy alcohol use, a viral infection, a genetic disorder, or problems with a person's metabolism.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Over 8 million Americans live with neurodegenerative diseases, a group of conditions where the brain and nervous system deteriorate over time.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Over 120 million Americans live with heart disease, the leading cause of death in the United States.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

American patients and taxpayers disproportionately fund the global R&D ecosystem that enables life- saving medical advances, while wealthy countries impose price controls that underpay by as much as 60% relative to their economic capacity. Adopting the Most Favored Nation (MFN) approach for price setting undermines U.S. leadership in medical innovation, hurts patients at home and abroad, and also impairs global progress against disease.

Over 100,000 Americans suffer from scleroderma, a disease that causes the immune system to attack the body.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Over 60,000 women in the United States are diagnosed each year with endometrial cancer, one of the few cancers still with rising mortality rates.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Over 3.8 million Americans, mostly women, but also some men are living with breast cancer. Even with available treatments, more than 40,000 women die each year in America, making it the second deadliest cancer.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Over 150,000 Americans are diagnosed with colon cancer every year, making it one of the most common cancers. And it kills over 50,000 Americans each year, making it one of the deadliest.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Nearly one in eight men in the United States are diagnosed with prostate cancer in their lifetime. Every year, almost 300,000 discover that they have prostate cancer and over 30,000 die from it, making it one of the most survivable cancers and also the second highest cause of cancer death among men.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

American patients enjoy significant health benefits from groundbreaking medicines developed right here at home. Yet, despite rhetoric to the contrary, the prices Americans pay for these innovative treatments are substantially below their true societal value. If other countries paid for them fairly, we would enjoy more breakthroughs, faster, with more savings.

Over 30,000 Americans are living with amyotrophic lateral sclerosis (ALS).

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Over 2 million Americans are diagnosed with cancer each year.

Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

Over 1.5 million Americans are living with blood cancers—leukemia, lymphoma, myeloma. Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.

More than 1.5 million Americans live with lupus. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.

More than 1 million Americans live with rheumatoid arthritis, a painful autoimmune disease that can damage joints, skin, eyes, lungs, and more. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.

About 40,000 children and adults in the US and approximately a hundred thousand people worldwide live with cystic fibrosis or CF. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.

About 20,000 American women are diagnosed with ovarian cancer each year. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.

The US system of private, market-based pricing is the foundation of America’s global leadership in biomedical innovation. Proposals to import government price controls from wealthy foreign trade competitors ignore the extraordinary value that the US pricing system delivers to patients, employers, taxpayers, and health plans.

When measuring the value of new medicines, some countries rely on an outdated and incomplete methodology that understates the true value of innovative treatments. Setting prices in the U.S. based on these artificially low estimates of value would reduce investment in biomedical R&D and yield fewer novel medicines that address critical unmet needs of patients.